These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18230052)

  • 41. Targeting the Hedgehog Pathway in Pediatric Medulloblastoma.
    Huang SY; Yang JY
    Cancers (Basel); 2015 Oct; 7(4):2110-23. PubMed ID: 26512695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets.
    Schmidt AL; Brunetto AL; Schwartsmann G; Roesler R; Abujamra AL
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):335-48. PubMed ID: 20438440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hitting the target in medulloblastoma therapy.
    Bradbury J
    Drug Discov Today; 2004 Dec; 9(23):994-5. PubMed ID: 15574311
    [No Abstract]   [Full Text] [Related]  

  • 44. Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment.
    Wijaya J; Gose T; Schuetz JD
    Pharmacol Rev; 2020 Jul; 72(3):668-691. PubMed ID: 32571983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
    Medeiros M; Candido MF; Valera ET; Brassesco MS
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6161-6200. PubMed ID: 34333711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma.
    Kumar S; Arwind DA; Kumar B H; Pandey S; Nayak R; Vithalkar MP; Kumar N; Pai KSR
    Transl Oncol; 2024 Aug; 46():102023. PubMed ID: 38852276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On His Own Two Feet.
    Guevara NV
    Anesthesiology; 2015 Oct; 123(4):961-2. PubMed ID: 25799036
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma.
    Umbach GE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6538. PubMed ID: 4063997
    [No Abstract]   [Full Text] [Related]  

  • 49. Medulloblastoma: molecular pathways and histopathological classification.
    Borowska A; Jóźwiak J
    Arch Med Sci; 2016 Jun; 12(3):659-66. PubMed ID: 27279861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Existence of medulloblastoma].
    DEFILIPPO RA
    Dia Med; 1955 Jan; 27(4):95-8. PubMed ID: 14352935
    [No Abstract]   [Full Text] [Related]  

  • 51. Medulloblastoma: origins.
    McCarthy N
    Nat Rev Cancer; 2011 Jan; 11(2):80. PubMed ID: 21436788
    [No Abstract]   [Full Text] [Related]  

  • 52. Advances in Genomics Explain Medulloblastoma Behavior at the Bedside.
    Kuzan-Fischer CM; Guerreiro Stucklin AS; Taylor MD
    Neurosurgery; 2017 Sep; 64(CN_suppl_1):21-26. PubMed ID: 28899050
    [No Abstract]   [Full Text] [Related]  

  • 53. Medulloblastoma - Introduction.
    Klein O
    Neurochirurgie; 2021 Feb; 67(1):1-2. PubMed ID: 32866498
    [No Abstract]   [Full Text] [Related]  

  • 54. Medulloblastoma: Pump up the volume.
    Seton-Rogers S
    Nat Rev Cancer; 2012 Sep; 12(9):583. PubMed ID: 22898543
    [No Abstract]   [Full Text] [Related]  

  • 55. HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.
    Pei Y; Liu KW; Wang J; Garancher A; Tao R; Esparza LA; Maier DL; Udaka YT; Murad N; Morrissy S; Seker-Cin H; Brabetz S; Qi L; Kogiso M; Schubert S; Olson JM; Cho YJ; Li XN; Crawford JR; Levy ML; Kool M; Pfister SM; Taylor MD; Wechsler-Reya RJ
    Cancer Cell; 2016 Mar; 29(3):311-323. PubMed ID: 26977882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.
    Vorobyeva AG; Lee R; Miller S; Longen C; Sharoni M; Kandelwal PJ; Kim FJ; Marenda DR; Saunders AJ
    J Biol Chem; 2014 Nov; 289(48):33258-74. PubMed ID: 25281744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.
    Matsuda Y; Wakai T; Kubota M; Osawa M; Hirose Y; Sakata J; Kobayashi T; Fujimaki S; Takamura M; Yamagiwa S; Aoyagi Y
    Int J Clin Exp Pathol; 2014; 7(4):1299-313. PubMed ID: 24817927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide induction.
    Meyers-Needham M; Lewis JA; Gencer S; Sentelle RD; Saddoughi SA; Clarke CJ; Hannun YA; Norell H; da Palma TM; Nishimura M; Kraveka JM; Khavandgar Z; Murshed M; Cevik MO; Ogretmen B
    Mol Cancer Ther; 2012 May; 11(5):1092-102. PubMed ID: 22452947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases.
    Pizem J; Popovic M; Cör A
    J Neurooncol; 2011 Jul; 103(3):459-67. PubMed ID: 20953661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
    Enguita-Germán M; Gurrea M; Schiapparelli P; Zhu TS; Crowley JG; Hamm LL; Costello MA; He X; Talsma CE; Flack CG; Hervey-Jumper SL; Heth JA; Muraszko KM; Rey JA; Fan X; Castresana JS
    J Neurooncol; 2011 Jun; 103(2):247-53. PubMed ID: 20853134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.